Neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancer: A pilot trial.

Xue, JQ; Niu, N; Wang, S; Chen, GL; Qiu, F; Zhao, Y; Xing, F; Zheng, XY; Tu, W; Li, K; Zhao, H; Tang, MY; Xu, QS; Liu, C; Zhao, YF; Jiang, XF; Huo, SW; Pang, Z; Zhang, DL; Liu, CG

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索